The aldosterone receptor antagonist spironolactone prevents peritoneal inflammation and fibrosis. [electronic resource]
Producer: 20140926Description: 839-50 p. digitalISSN:- 1530-0307
- Aldosterone -- chemistry
- Angiotensin-Converting Enzyme Inhibitors -- therapeutic use
- Animals
- Anti-Inflammatory Agents -- therapeutic use
- Cilazapril -- therapeutic use
- Dialysis Solutions -- chemistry
- Disease Models, Animal
- Drug Therapy, Combination
- Lymphocytes -- drug effects
- Macrophages -- drug effects
- Male
- Mineralocorticoid Receptor Antagonists -- therapeutic use
- Peritoneal Dialysis, Continuous Ambulatory -- adverse effects
- Peritoneal Fibrosis -- etiology
- Peritoneum -- drug effects
- Peritonitis -- etiology
- Random Allocation
- Rats
- Rats, Wistar
- Receptors, Mineralocorticoid -- chemistry
- Spironolactone -- therapeutic use
- Transforming Growth Factor beta1 -- analysis
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.